 | • レポートコード：MRC2-11QY12048 • 出版社/出版日：QYResearch / 2020年11月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は巨細胞性動脈炎治療のグローバル市場について調査・分析したレポートです。種類別（コルチコステロイド療法、アジュバント剤）市場規模、用途別（病院、クリニック、ASC、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別巨細胞性動脈炎治療の競争状況、市場シェア ・世界の巨細胞性動脈炎治療市場：種類別市場規模 2015年-2020年（コルチコステロイド療法、アジュバント剤） ・世界の巨細胞性動脈炎治療市場：種類別市場規模予測 2021年-2026年（コルチコステロイド療法、アジュバント剤） ・世界の巨細胞性動脈炎治療市場：用途別市場規模 2015年-2020年（病院、クリニック、ASC、その他） ・世界の巨細胞性動脈炎治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、ASC、その他） ・北米の巨細胞性動脈炎治療市場分析：米国、カナダ ・ヨーロッパの巨細胞性動脈炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの巨細胞性動脈炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の巨細胞性動脈炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの巨細胞性動脈炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johns Hopkins Hospital、Fortis Healthcare、American College of Rheumatology、Duke University Health System、Lahey Clinic Foundation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Market Analysis and Insights: Global Giant Cell Arteritis Treatment Market
The global Giant Cell Arteritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Giant Cell Arteritis Treatment Scope and Market Size
Giant Cell Arteritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Giant Cell Arteritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
…
Market segment by Type, the product can be split into
Corticosteroid Therapy
Adjuvant Agents
Market segment by Application, split into
Hospitals
Clinics
ASCs
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Giant Cell Arteritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Corticosteroid Therapy
1.4.3 Adjuvant Agents
1.5 Market by Application
1.5.1 Global Giant Cell Arteritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 ASCs
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Giant Cell Arteritis Treatment Market Perspective (2015-2026)
2.2 Global Giant Cell Arteritis Treatment Growth Trends by Regions
2.2.1 Giant Cell Arteritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Giant Cell Arteritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Giant Cell Arteritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Giant Cell Arteritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Giant Cell Arteritis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Giant Cell Arteritis Treatment Players by Market Size
3.1.1 Global Top Giant Cell Arteritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Giant Cell Arteritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Giant Cell Arteritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Giant Cell Arteritis Treatment Market Concentration Ratio
3.2.1 Global Giant Cell Arteritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Giant Cell Arteritis Treatment Revenue in 2019
3.3 Giant Cell Arteritis Treatment Key Players Head office and Area Served
3.4 Key Players Giant Cell Arteritis Treatment Product Solution and Service
3.5 Date of Enter into Giant Cell Arteritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Giant Cell Arteritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
5.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Giant Cell Arteritis Treatment Market Size (2015-2020)
6.2 Giant Cell Arteritis Treatment Key Players in North America (2019-2020)
6.3 North America Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
6.4 North America Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Giant Cell Arteritis Treatment Market Size (2015-2020)
7.2 Giant Cell Arteritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
7.4 Europe Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Giant Cell Arteritis Treatment Market Size (2015-2020)
8.2 Giant Cell Arteritis Treatment Key Players in China (2019-2020)
8.3 China Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
8.4 China Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Giant Cell Arteritis Treatment Market Size (2015-2020)
9.2 Giant Cell Arteritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
9.4 Japan Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Giant Cell Arteritis Treatment Market Size (2015-2020)
10.2 Giant Cell Arteritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Giant Cell Arteritis Treatment Market Size (2015-2020)
11.2 Giant Cell Arteritis Treatment Key Players in India (2019-2020)
11.3 India Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
11.4 India Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Giant Cell Arteritis Treatment Market Size (2015-2020)
12.2 Giant Cell Arteritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Giant Cell Arteritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Giant Cell Arteritis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johns Hopkins Hospital
13.1.1 Johns Hopkins Hospital Company Details
13.1.2 Johns Hopkins Hospital Business Overview
13.1.3 Johns Hopkins Hospital Giant Cell Arteritis Treatment Introduction
13.1.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2015-2020))
13.1.5 Johns Hopkins Hospital Recent Development
13.2 Fortis Healthcare
13.2.1 Fortis Healthcare Company Details
13.2.2 Fortis Healthcare Business Overview
13.2.3 Fortis Healthcare Giant Cell Arteritis Treatment Introduction
13.2.4 Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2015-2020)
13.2.5 Fortis Healthcare Recent Development
13.3 American College of Rheumatology
13.3.1 American College of Rheumatology Company Details
13.3.2 American College of Rheumatology Business Overview
13.3.3 American College of Rheumatology Giant Cell Arteritis Treatment Introduction
13.3.4 American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2015-2020)
13.3.5 American College of Rheumatology Recent Development
13.4 Duke University Health System
13.4.1 Duke University Health System Company Details
13.4.2 Duke University Health System Business Overview
13.4.3 Duke University Health System Giant Cell Arteritis Treatment Introduction
13.4.4 Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2015-2020)
13.4.5 Duke University Health System Recent Development
13.5 Lahey Clinic Foundation
13.5.1 Lahey Clinic Foundation Company Details
13.5.2 Lahey Clinic Foundation Business Overview
13.5.3 Lahey Clinic Foundation Giant Cell Arteritis Treatment Introduction
13.5.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2015-2020)
13.5.5 Lahey Clinic Foundation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Giant Cell Arteritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Giant Cell Arteritis Treatment Revenue
Table 3. Ranking of Global Top Giant Cell Arteritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Corticosteroid Therapy
Table 6. Key Players of Adjuvant Agents
Table 7. Global Giant Cell Arteritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Giant Cell Arteritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Giant Cell Arteritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Giant Cell Arteritis Treatment Market Share by Regions (2015-2020)
Table 11. Global Giant Cell Arteritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Giant Cell Arteritis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Giant Cell Arteritis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Giant Cell Arteritis Treatment Players
Table 18. Global Giant Cell Arteritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Giant Cell Arteritis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Giant Cell Arteritis Treatment as of 2019)
Table 21. Global Giant Cell Arteritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Giant Cell Arteritis Treatment Product Solution and Service
Table 24. Date of Enter into Giant Cell Arteritis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Giant Cell Arteritis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Giant Cell Arteritis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Giant Cell Arteritis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 34. North America Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 36. North America Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 40. Europe Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 42. Europe Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 46. China Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 48. China Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 52. Japan Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 54. Japan Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 64. India Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 66. India Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Giant Cell Arteritis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Giant Cell Arteritis Treatment Market Share (2019-2020)
Table 70. Central & South America Giant Cell Arteritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Giant Cell Arteritis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Giant Cell Arteritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Giant Cell Arteritis Treatment Market Share by Application (2015-2020)
Table 74. Johns Hopkins Hospital Company Details
Table 75. Johns Hopkins Hospital Business Overview
Table 76. Johns Hopkins Hospital Product
Table 77. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2015-2020) (Million US$)
Table 78. Johns Hopkins Hospital Recent Development
Table 79. Fortis Healthcare Company Details
Table 80. Fortis Healthcare Business Overview
Table 81. Fortis Healthcare Product
Table 82. Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2015-2020) (Million US$)
Table 83. Fortis Healthcare Recent Development
Table 84. American College of Rheumatology Company Details
Table 85. American College of Rheumatology Business Overview
Table 86. American College of Rheumatology Product
Table 87. American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2015-2020) (Million US$)
Table 88. American College of Rheumatology Recent Development
Table 89. Duke University Health System Company Details
Table 90. Duke University Health System Business Overview
Table 91. Duke University Health System Product
Table 92. Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2015-2020) (Million US$)
Table 93. Duke University Health System Recent Development
Table 94. Lahey Clinic Foundation Company Details
Table 95. Lahey Clinic Foundation Business Overview
Table 96. Lahey Clinic Foundation Product
Table 97. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2015-2020) (Million US$)
Table 98. Lahey Clinic Foundation Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Giant Cell Arteritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Corticosteroid Therapy Features
Figure 3. Adjuvant Agents Features
Figure 4. Global Giant Cell Arteritis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. ASCs Case Studies
Figure 8. Others Case Studies
Figure 9. Giant Cell Arteritis Treatment Report Years Considered
Figure 10. Global Giant Cell Arteritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Giant Cell Arteritis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Giant Cell Arteritis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Giant Cell Arteritis Treatment Market Share by Players in 2019
Figure 15. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Giant Cell Arteritis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Treatment Revenue in 2019
Figure 17. North America Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Giant Cell Arteritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
形質細胞新生物治療の世界市場（～2026年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…- グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年） Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Globoid Cell Leukodystrophy Treatment S…
- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…